{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:46:10Z","timestamp":1770831970451,"version":"3.50.1"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.05.002","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T13:20:28Z","timestamp":1243603228000},"page":"B90-B102","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S2","title":["Genetic polymorphisms in host response to meningococcal infection: The role of susceptibility and severity genes"],"prefix":"10.1016","volume":"27","author":[{"given":"Victoria","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hibberd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2009.05.002_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM198803243181202","article-title":"Genetic and environmental influences on premature death in adult adoptees","volume":"318","author":"Sorensen","year":"1988","journal-title":"N Engl J Med"},{"issue":"7145","key":"10.1016\/j.vaccine.2009.05.002_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"WTCCC","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0950268803008513","article-title":"Sibling familial risk ratio of meningococcal disease in UK Caucasians","volume":"130","author":"Haralambous","year":"2003","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib4","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0950268800059367","article-title":"Secretor status, smoking and carriage of Neisseria meningitidis","volume":"104","author":"Blackwell","year":"1990","journal-title":"Epidemiol Infect"},{"issue":"8501","key":"10.1016\/j.vaccine.2009.05.002_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(86)92103-3","article-title":"Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcuspneumoniae","volume":"2","author":"Blackwell","year":"1986","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.002_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1699-0463.1993.tb00181.x","article-title":"ABH secretor status, as judged by the Lewis phenotypes, in Norwegian survivors from meningococcal disease","volume":"101","author":"Kornstad","year":"1993","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.gene.6364442","article-title":"Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease","volume":"9","author":"Callaghan","year":"2008","journal-title":"Genes Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1977.9.issue-2.09","article-title":"Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence","volume":"9","author":"Edwards","year":"1977","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/oxfordjournals.aje.a112714","article-title":"Meningococcal colonization and infection in children and their household contacts","volume":"109","author":"Marks","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"6640","key":"10.1016\/j.vaccine.2009.05.002_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/40967","article-title":"Seeking wisdom in innate immunity","volume":"388","author":"Fearon","year":"1997","journal-title":"Nature"},{"issue":"5258","key":"10.1016\/j.vaccine.2009.05.002_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.272.5258.50","article-title":"The instructive role of innate immunity in the acquired immune response","volume":"272","author":"Fearon","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","article-title":"Innate immunity: the virtues of a nonclonal system of recognition","volume":"91","author":"Medzhitov","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/JB.90.3.696-703.1965","article-title":"High susceptibility of Strain A mice to endotoxin and endotoxin-red blood cell mixtures","volume":"90","author":"Heppner","year":"1965","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.120.2.422","article-title":"The genetic mapping of a defective LPS response gene in C3H\/HeJ mice","volume":"120","author":"Watson","year":"1978","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib18","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.118.6.2088","article-title":"The response of recombinant inbred strains of mice to bacterial lipopolysaccharides","volume":"118","author":"Watson","year":"1977","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1128\/IAI.56.8.1950-1955.1988","article-title":"Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection","volume":"56","author":"Woods","year":"1988","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MMBR.46.2.162-190.1982","article-title":"The meningococcus and mechanisms of pathogenicity","volume":"46","author":"DeVoe","year":"1982","journal-title":"Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.002_bib21","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1073\/pnas.1031605100","article-title":"Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility","volume":"100","author":"Smirnova","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.inf.0000195595.22547.fe","article-title":"Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy","volume":"25","author":"Faber","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1651-2227.2008.01163.x","article-title":"A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease","volume":"98","author":"Faber","year":"2009","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/322798","article-title":"A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease","volume":"184","author":"Read","year":"2001","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.002_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.inf.0000095431.15606.68","article-title":"Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children","volume":"22","author":"Allen","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib27","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.176.4.2373","article-title":"Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling","volume":"176","author":"Massari","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.002_bib28","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1128\/IAI.00615-08","article-title":"Important role for Toll-like receptor 9 in host defense against meningococcal sepsis","volume":"76","author":"Sjolinder","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0952-7915(99)00046-1","article-title":"Tlr4: central component of the sole mammalian LPS sensor","volume":"12","author":"Beutler","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00062752-200201000-00002","article-title":"Toll-like receptors: how they work and what they do","volume":"9","author":"Beutler","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.002_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s000110050511","article-title":"The Lps locus: genetic regulation of host responses to bacterial lipopolysaccharide","volume":"48","author":"Qureshi","year":"1999","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(01)78001-7","article-title":"Toll-like receptors and innate immunity","volume":"78","author":"Akira","year":"2001","journal-title":"Adv Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.20030701","article-title":"Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections","volume":"198","author":"Medvedev","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.05.002_bib34","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2004"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.002_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(03)00740-0","article-title":"Host genetic determinants of Neisseria meningitidis infections","volume":"3","author":"Emonts","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.05.002_bib37","first-page":"57","article-title":"Complement deficiencies and meningococcal disease","volume":"86","author":"Densen","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2009.05.002_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198304213081601","article-title":"Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease","volume":"308","author":"Ellison","year":"1983","journal-title":"N Engl J Med"},{"issue":"8663","key":"10.1016\/j.vaccine.2009.05.002_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(89)90712-5","article-title":"Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups","volume":"2","author":"Fijen","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/CMR.00009-08","article-title":"Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis","volume":"21","author":"Tebruegge","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/17843286.1993.11718283","article-title":"Recurrent meningococcal infections in a patient with congenital C5 deficiency","volume":"48","author":"Bols","year":"1993","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib42","first-page":"16","article-title":"Recurrent bacterial meningitis in patients with genetic defects of terminal complement components","volume":"40","author":"Haeney","year":"1980","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.1988.00380060205036","article-title":"Chronic meningococcal meningitis. An association with C5 deficiency","volume":"148","author":"Rosen","year":"1988","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"Figueroa","year":"1993","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/515075","article-title":"Assessment of complement deficiency in patients with meningococcal disease in The Netherlands","volume":"28","author":"Fijen","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"9158","key":"10.1016\/j.vaccine.2009.05.002_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(98)08350-0","article-title":"Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease","volume":"353","author":"Hibberd","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/CDLI.11.4.806-807.2004","article-title":"Association between familial deficiency of mannose-binding lectin and mutations in the corresponding gene and promoter region","volume":"11","author":"Salimans","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9184","key":"10.1016\/j.vaccine.2009.05.002_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(99)02563-5","article-title":"Association of familial deficiency of mannose-binding lectin and meningococcal disease","volume":"354","author":"Bax","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.inf.0000256751.76218.7c","article-title":"Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood","volume":"26","author":"Faber","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(08)70261-5","article-title":"Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis","volume":"9","author":"Brouwer","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"7089","key":"10.1016\/j.vaccine.2009.05.002_bib51","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/bmj.314.7089.1229","article-title":"Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series","volume":"314","author":"Summerfield","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2009.05.002_bib52","series-title":"Meningococcal disease","first-page":"115","article-title":"Pathogenesis of meningococcal infections","author":"Brandtzaeg","year":"1995"},{"issue":"14","key":"10.1016\/j.vaccine.2009.05.002_bib53","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2009.05.002_bib54","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2009.05.002_bib56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.molimm.2003.12.002","article-title":"Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?","volume":"40","author":"Blom","year":"2004","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib57","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.142.4.856","article-title":"Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase","volume":"142","author":"Fearon","year":"1975","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib58","first-page":"291","article-title":"Properdin deficiency in a family with fulminant meningococcal infections","volume":"50","author":"Sjoholm","year":"1982","journal-title":"Clin Exp Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2009.05.002_bib59","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJM198704093161506","article-title":"Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination","volume":"316","author":"Densen","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2249.1999.01056.x","article-title":"Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n)","volume":"118","author":"Spath","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.1995.tb03780.x","article-title":"Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency","volume":"102","author":"Fijen","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molimm.2005.02.017","article-title":"Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis","volume":"43","author":"Bathum","year":"2006","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1172\/JCI200112023","article-title":"A family with complement factor D deficiency","volume":"108","author":"Biesma","year":"2001","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.002_bib64","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1182\/blood-2005-07-2820","article-title":"Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections","volume":"107","author":"Sprong","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.vaccine.2009.05.002_bib65","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/00365540600643203","article-title":"Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients","volume":"38","author":"Haralambous","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2249.1996.d01-777.x","article-title":"Heterozygous and homozygous factor H deficiency states in a Dutch family","volume":"105","author":"Fijen","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib67","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-3083.1989.tb02480.x","article-title":"Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease","volume":"30","author":"Nielsen","year":"1989","journal-title":"Scand J Immunol"},{"issue":"7240","key":"10.1016\/j.vaccine.2009.05.002_bib68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.05.002_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.01.075","article-title":"Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide","author":"McNeil","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.002_bib70","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/508775","article-title":"Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease","volume":"43","author":"Jack","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/IAI.63.1.73-81.1995","article-title":"Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils","volume":"63","author":"Sanders","year":"1995","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.002_bib72","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1086\/324662","article-title":"Relevance of Fc\u03b3 receptor and interleukin-10 polymorphisms for meningococcal disease","volume":"184","author":"van der Pol","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib73","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/infdis\/170.4.848","article-title":"Fc\u03b3 receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children","volume":"170","author":"Bredius","year":"1994","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib74","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1086\/514935","article-title":"Association of human Fc\u03b3 RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease","volume":"27","author":"Platonov","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S0950268802008087","article-title":"Fc\u03b3RIIa and Fc\u03b3RIIIb polymorphisms were not associated with meningococcal disease in Western Norway","volume":"130","author":"Smith","year":"2003","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib76","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10096-004-1167-8","article-title":"Relevance of genetically determined host factors to the prognosis of meningococcal disease","volume":"23","author":"Domingo","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(01)01047-6","article-title":"Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease","volume":"112","author":"Domingo","year":"2002","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2249.1998.00484.x","article-title":"Meningococcal disease and polymorphism of Fc\u03b3RIIa (CD32) in late complement component-deficient individuals","volume":"111","author":"Platonov","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib79","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2249.2000.01208.x","article-title":"The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals","volume":"120","author":"Fijen","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/clinids\/17.2.254","article-title":"Epidemic meningococcemia and purpura fulminans with induced protein C deficiency","volume":"17","author":"Powars","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"7 Suppl.","key":"10.1016\/j.vaccine.2009.05.002_bib81","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/00003246-200107001-00022","article-title":"Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C","volume":"29","author":"Faust","year":"2001","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib82","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0049-3848(89)90054-6","article-title":"The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease","volume":"55","author":"Brandtzaeg","year":"1989","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib83","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1097\/00003246-200008000-00054","article-title":"Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria","volume":"28","author":"Oragui","year":"2000","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.002_bib84","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/adc.66.11.1296","article-title":"Deficiency of prostacyclin production in meningococcal shock","volume":"66","author":"Heyderman","year":"1991","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/mpat.1996.0112","article-title":"Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium","volume":"22","author":"Heyderman","year":"1997","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib86","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0037-1615703","article-title":"Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease","volume":"85","author":"Eling","year":"2001","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM200108093450603","article-title":"Dysfunction of endothelial protein C activation in severe meningococcal sepsis","volume":"345","author":"Faust","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","article-title":"Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease","volume":"57","author":"Brandtzaeg","year":"1990","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.002_bib89","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00006454-199801000-00023","article-title":"Homozygous Factor V Leiden mutation in a child with meningococcal purpura fulminans","volume":"17","author":"Sackesen","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.002_bib91","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00006454-199910000-00011","article-title":"Effect of the Factor V Leiden mutation on the severity of meningococcal disease","volume":"18","author":"Kondaveeti","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib92","first-page":"161","article-title":"The insertion\/deletion polymorphism in the t-PA gene does not significantly affect outcome of meningococcal disease","volume":"82","author":"Kondaveeti","year":"1999","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.vaccine.2009.05.002_bib93","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1097\/01.CCM.0000100122.57249.5D","article-title":"Role of functional plasminogen-activator-inhibitor-1 4G\/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children","volume":"31","author":"Haralambous","year":"2003","journal-title":"Crit Care Med"},{"issue":"9178","key":"10.1016\/j.vaccine.2009.05.002_bib94","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(98)09376-3","article-title":"Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock","volume":"354","author":"Westendorp","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib95","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00431-005-1673-4","article-title":"4G\/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia","volume":"164","author":"Geishofer","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2009.05.002_bib96","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/j.1538-7836.2007.02724.x","article-title":"4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia","volume":"5","author":"Binder","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9178","key":"10.1016\/j.vaccine.2009.05.002_bib97","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(99)02220-5","article-title":"4G\/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease","volume":"354","author":"Hermans","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0037-1613197","article-title":"Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes","volume":"88","author":"Yuksel","year":"2002","journal-title":"Thromb Haemost"},{"issue":"41","key":"10.1016\/j.vaccine.2009.05.002_bib99","doi-asserted-by":"crossref","first-page":"24216","DOI":"10.1074\/jbc.270.41.24216","article-title":"Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites","volume":"270","author":"Spek","year":"1995","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00439-007-0392-5","article-title":"Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia","volume":"122","author":"Binder","year":"2007","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib101","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1074\/jbc.M104444200","article-title":"Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme","volume":"277","author":"Schneider","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib102","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2004.00557.x","article-title":"A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease","volume":"2","author":"Kremer Hovinga","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib103","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2008.02841.x","article-title":"Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children","volume":"6","author":"Emonts","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.002_bib104","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.169.1.333","article-title":"The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome","volume":"169","author":"Waage","year":"1989","journal-title":"J Exp Med"},{"issue":"26","key":"10.1016\/j.vaccine.2009.05.002_bib105","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"issue":"8942","key":"10.1016\/j.vaccine.2009.05.002_bib106","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0140-6736(95)90059-4","article-title":"Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?","volume":"345","author":"Levin","year":"1995","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib107","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0923-2494(89)90029-1","article-title":"The macrophage resistance gene Lsh\/Ity\/Bcg","volume":"140","author":"Blackwell","year":"1989","journal-title":"Res Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib108","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0092-8674(93)90135-D","article-title":"Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg","volume":"73","author":"Vidal","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib109","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03401551","article-title":"Nramp transfection transfers Ity\/Lsh\/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways","volume":"1","author":"Barton","year":"1995","journal-title":"Mol Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jmg.33.8.672","article-title":"Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35","volume":"33","author":"Shaw","year":"1996","journal-title":"J Med Genet"},{"issue":"9046","key":"10.1016\/j.vaccine.2009.05.002_bib111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(96)06413-6","article-title":"Genetic influence on cytokine production and fatal meningococcal disease","volume":"349","author":"Westendorp","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib112","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/174.4.878","article-title":"Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease","volume":"174","author":"Nadel","year":"1996","journal-title":"J Infect Dis"},{"issue":"9059","key":"10.1016\/j.vaccine.2009.05.002_bib113","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(05)63055-3","article-title":"Genetic influence on cytokine production in meningococcal disease","volume":"349","author":"Booy","year":"1997","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.002_bib114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.gene.6364020","article-title":"Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?","volume":"4","author":"Balding","year":"2003","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/315889","article-title":"An interleukin-1 genotype is associated with fatal outcome of meningococcal disease","volume":"182","author":"Read","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib116","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood.V90.3.1101","article-title":"The pattern of interleukin-1\u03b2 (IL-1\u03b2) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections","volume":"90","author":"van Deuren","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vaccine.2009.05.002_bib117","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-138-7-200304010-00009","article-title":"Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease","volume":"138","author":"Read","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib118","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1373\/clinchem.2005.058537","article-title":"Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia","volume":"52","author":"Endler","year":"2006","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.002_bib119","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1086\/341497","article-title":"Variable number tandem repeat polymorphism of the interleukin-1 receptor antagonist gene in meningococcal disease","volume":"35","author":"Carrol","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.002_bib120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/513759","article-title":"Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score","volume":"25","author":"Kornelisse","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.002_bib121","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.05.002_bib122","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.002_bib123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/gm19","article-title":"Genome-wide association studies are coming for human infectious diseases","volume":"1","author":"Davila","year":"2009","journal-title":"Genome Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T07:08:19Z","timestamp":1684998499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":123,"alternative-id":["S0264410X09006677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}